New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2012
07:26 EDTILMN, RHHBYIllumina downgraded to Neutral from Outperform at RW Baird
RW Baird downgraded Ilumina as the firm believes that the outlook for the company's partnership with BGI has been clouded, and notes that a potential takeover of Ilumina by Roche (RHHBY) fell through previously. Target $54.
News For ILMN;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:51 EDTRHHBYRoche catching up fast to Bristol-Myers in immuno-oncology, says Jefferies
Subscribe for More Information
August 26, 2015
16:12 EDTILMNIllumina initiated with a Buy at Cantor
Target $265.
07:28 EDTILMNIllumina added to Focus List at Citi
Subscribe for More Information
August 25, 2015
05:09 EDTILMNIllumina enters oncology collaboration with Burning Rock
Subscribe for More Information
August 24, 2015
12:01 EDTRHHBYRoche buys nucleic acid purification technology from Lumora
Roche has signed a definitive asset purchase agreement with Lumora for products associated with the patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.
08:29 EDTILMNWilliam Blair to hold a field trip
Subscribe for More Information
August 23, 2015
12:35 EDTRHHBYBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
09:38 EDTRHHBYUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use